Himension Capital (Singapore)’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.4M	Buy	92,481 +8,091	+10%	+$427K	0.34%	36
2025 Q4	$4.43M	Buy	84,390 +12,051	+17%	+$722K	0.27%	35
2025 Q3	$4.69M	Sell	72,339 -10,781	-13%	-$619K	0.29%	32
2025 Q2	$4.04M	Sell	83,120 -10,454	-11%	-$405K	0.32%	29
2025 Q1	$3.18M	Buy	93,574 +12,804	+16%	+$543K	0.27%	33
2024 Q4	$3.18M	Sell	80,770 -375	-0.5%	-$17.7K	0.22%	31
2024 Q3	$3.81M	Buy	81,145 +3,603	+5%	+$183K	0.3%	20
2024 Q2	$4.19M	Buy	77,542 +8,527	+12%	+$493K	0.3%	22
2024 Q1	$4.7M	Hold	69,015	–	–	0.35%	23
2023 Q4	$4.32M	Buy	+69,015	New	+$3.82M	0.39%	19
2021 Q4	–	Sell	-188,634	Closed	-$21.1M	–	16
2021 Q3	$21.1M	Buy	188,634 +31,300	+20%	+$3.93M	1.65%	13
2021 Q2	$25.5M	Buy	+157,334	New	+$19.1M	2.47%	10